Table 1.
Demographics and clinical characteristics of patients with migraine
| Patients with migraine | |
|---|---|
| n (M/F) | 606 (73/533) |
| Age, years | 45.2 ± 12.0 |
| Diagnosis, n (%) | |
| Migraine without aura | 483 (79.7) |
| Migraine with aura | 139 (22.9) |
| Chronic migraine | 84 (13.9) |
| Onset of migrainea, years | 20.2 ± 10.2 |
| Smoking, n (%) | |
| Never | 457 (75.4) |
| Past | 103 (17.0) |
| Current | 46 (7.6) |
| Alcohol intakea, n (%) | |
| Never | 291 (48.0) |
| <1 day/week | 223 (36.8) |
| 1–2 days/week | 60 (9.9) |
| 3–5 days/week | 17 (2.8) |
| 6–7 days/week | 13 (2.1) |
| Caffeine, n (%) | 560 (92.4) |
| Caffeinea, cups/day | 2.7 ± 2.1 |
| Accompanying symptoms, n (%) | |
| Nausea | 424 (70.0) |
| Photophobia | 439 (72.4) |
| Phonophobia | 438 (72.3) |
| Osmophobia | 312 (51.5) |
| Allodynia | 102 (16.8) |
| bAcute headache medication, n (%) | 596 (98.3) |
| bPreventive headache medication, n (%) | 384 (63.4) |
| Comorbidities, n (%) | 269 (44.4) |
| Use of infection protective wear, n (%) | 603 (99.5) |
| Mask, n (%) | 603 (99.5) |
| Mask usagea (h/d) | 6.7 ± 4.0 |
| Face shield, n (%) | 37 (6.1) |
| Face shield usagea (h/d) | 4.6 ± 3.1 |
| PPE, n (%) | 10 (1.7) |
| PPE usage (h/d) | 4.0 ± 3.1 |
| Evaluation period after the end of the state of emergency (months) | 2.6 ± 1.8 |
PPE personal protective equipment
aMissing values (onset of migraine = 6, alcohol intake = 2, caffeine = 11, mask time = 22, and face shield time = 1) were excluded
bAt the time of the study